MedPath

PARTNERS2: A cluster randomised control trial of a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses

Not Applicable
Completed
Conditions
Schizophrenia, bipolar disorder or psychosis
Mental and Behavioural Disorders
Schizophrenia, or bipolar, or other types of psychosis
Registration Number
ISRCTN95702682
Lead Sponsor
Birmingham and Solihull Mental Health Foundation Trust
Brief Summary

2019 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/30616552 qualitative formative evaluation (added 20/11/2019) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33785568/ (added 27/10/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33583478/ epidemiological medical records review (added 21/11/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37078520/ outcome measures (added 21/11/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
198
Inclusion Criteria

1. Registered with a participating GP practice
2. Aged 18 years and over
3. A clinical diagnosis of schizophrenia, bipolar, or other types of psychosis schizoaffective disorder (including lifetime and current) or has evidence of chronic psychoses [care clusters 11 and 12]

Exclusion Criteria

1. Inability to understand and complete questionnaires
2. Inability to understand English (or access to translation services)
3. Inability to give informed consent
4. Currently receiving crisis care or care in a secure setting

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath